Search Course Outline

Search

Showing 25 course outlines from 6720 matches

3676

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2024 Semester Two (1245)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
3677

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2023 Semester Two (1235)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
3678

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2022 Semester Two (1225)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
3679

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2021 Semester Two (1215)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
3680

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2020 Semester Two (1205)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
3681

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2025 Semester One (1253)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
3682

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2024 Semester One (1243)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
3683

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2023 Semester One (1233)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
3684

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2022 Semester One (1223)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
3685

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2021 Semester One (1213)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
3686

MEDSCI 319

: Molecular Pharmacology
2025 Semester One (1253)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
3687

MEDSCI 319

: Molecular Pharmacology
2024 Semester One (1243)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
3688

MEDSCI 319

: Molecular Pharmacology
2023 Semester One (1233)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
3689

MEDSCI 319

: Molecular Pharmacology
2022 Semester One (1223)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
3690

MEDSCI 319

: Molecular Pharmacology
2021 Semester One (1213)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
3691

MEDSCI 320

: Pharmacology of the Brain and Body
2025 Semester Two (1255)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
3692

MEDSCI 320

: Pharmacology of the Brain and Body
2024 Semester Two (1245)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
3693

MEDSCI 320

: Pharmacology of the Brain and Body
2023 Semester Two (1235)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
3694

MEDSCI 320

: Pharmacology of the Brain and Body
2022 Semester Two (1225)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
3695

MEDSCI 320

: Pharmacology of the Brain and Body
2021 Semester Two (1215)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
3696

MEDSCI 321

: Special Topic: Concepts in Pharmacology
2022 Semester One (1223)
Explores the cellular and molecular mechanisms of drug action plus drug discovery and development from the perspective of in silico modelling, biochemical assessment, intracellular signalling and human disease. Considers the pharmacokinetic processes of input, distribution and elimination involved in achieving clinically-relevant drug concentrations. Describes the link between concentration and effect and the time course of effect. Explores factors such as disease progression, drug metabolism, drug-drug interactions, pharmacogenetics, use in selected populations and in various pathological conditions that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from BIOSCI 203, MEDSCI 203, 205
Restriction: MEDSCI 303, 306, 318, 319, 735
3697

MEDSCI 700

: Drug Discovery Biology
2025 Semester One (1253)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
3698

MEDSCI 700

: Drug Discovery Biology
2024 Semester One (1243)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
3699

MEDSCI 700

: Drug Discovery Biology
2023 Semester One (1233)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
3700

MEDSCI 700

: Drug Discovery Biology
2021 Semester One (1213)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions